Can Head and Neck Cancer Recur After Robotic Surgery?

Head and neck cancer can recur after robotic surgery, including TORS. The risk depends heavily on the original stage, whether margins were clear, HPV status and whether lymph nodes were involved. HPV-positive oropharyngeal cancers have significantly lower recurrence rates than HPV-negative disease. Most recurrences appear within the first two years. After five years without disease, the risk drops sharply.

According to Prof. Dr. Sandeep Nayak, Surgical Oncologist in India, “Head and neck cancer recurrence after TORS is real, but the numbers are more encouraging than most patients expect, especially for HPV-positive disease. The surveillance schedule isn’t optional, it’s what catches recurrence early enough to treat it. A recurrence found at three months on clinical examination is a very different situation from one found a year later when the patient stopped coming for follow up.”

Stage, margins, biology and nodal status. All four feed into the risk.

• Surgical margin status: Clear margins after TORS significantly reduce local recurrence risk. Close or positive margins raise it. Some patients need adjuvant radiation to the primary site specifically because of margin findings on pathology.
• Lymph node involvement: Positive nodes at surgery mean higher risk of regional and distant recurrence. Neck dissection, performed alongside or after TORS, addresses regional nodes. Positive nodes usually trigger adjuvant radiation or chemoradiation.
• HPV status: HPV-positive oropharyngeal cancer, base of tongue and tonsil, has consistently better outcomes than HPV-negative disease. Three-year recurrence rates for HPV-positive TORS patients in published series sit below 15 percent. HPV-negative disease is more aggressive and recurs more often.
• Stage at surgery: Stage I and II disease treated with TORS alone has low recurrence rates. Stage III and IV disease with nodal involvement needs adjuvant treatment and carries a higher long-term recurrence risk even when surgery is successful.

For patients whose recurrence workup or salvage plan involves further minimally invasive surgery, robotic cancer surgery remains an option for selected recurrences in anatomically accessible sites.

Structured surveillance. Not passive monitoring.

• Clinical examination schedule: Every 6 to 8 weeks in the first year, every 3 months in year two, then less frequently. The surgeon examines the primary site, neck and oral cavity at every visit. This is when most recurrences are found first.
• Nasendoscopy: Flexible scope examination of the primary site including base of tongue, tonsil, pharynx and larynx. Allows direct visualisation of areas not visible on external examination. Done at each follow up.
• PET-CT imaging: At 3 to 6 months post-treatment to confirm complete response. Repeated if symptoms develop or examination raises concern. The most sensitive tool for detecting occult regional or distant recurrence.
• Salvage options: Local recurrence after TORS can sometimes be re-resected robotically. Regional neck recurrence may be salvage dissected. Distant metastases are managed with systemic treatment. Early detection is what keeps salvage surgery on the table.

For patients wanting to understand what TORS involves and what the procedure itself achieves, our blog on TORS surgery covers the full picture.

Dr. Sandeep Nayak has spent 24 years in surgical oncology. He holds DNB qualifications in Surgical Oncology and General Surgery, plus a fellowship in Laparoscopic and Robotic Onco Surgery. He performs TORS for oropharyngeal and base of tongue cancers, MIND neck dissection, and RABIT thyroid surgery, integrating recurrence surveillance into the post-surgical plan from the first consultation so patients understand the follow up commitment before they leave theatre.

High-volume TORS surgery means the margin decisions, neck dissection planning and adjuvant therapy discussions happen with a surgeon who reads this anatomy every week, not occasionally. That familiarity is what separates a good outcome from a preventable recurrence. Call +91 8104310753 to book your consultation.

Disclaimer: This blog is for informational purposes only and is not a substitute for professional medical advice.